Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatitis C virus RNA-dependent RNA polymerase, commonly referred to as NS5B, is a viral enzyme essential for the replication of the HCV genome. It catalyzes the synthesis of new viral RNA strands using an existing RNA template, a process central to the life cycle of HCV and a key target for antiviral drug development. NS5B operates within a multi-protein replication complex that includes other nonstructural proteins and host factors. Due to its essential role in viral replication and absence from uninfected human cells, HCV RdRp/NS5B has been extensively targeted by direct acting antivirals (DAAs).
Chain termination (nucleoside analogs) and non-nucleoside inhibition of polymerase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C Virus RNA-Dependent RNA Polymerase (HCV RdRp).